Author:
Zhong Yiyue,Zhu Yanwen,Li Jiayan,Yang Xiaowei,Feng Zhiying,Liu Haipeng,Liang Zhu,Lin Baoquan,Liu Zhifeng,Wang Xin,Luo Weibin,Zhu Jian,Li Bin,Lai Shangdao,Jiang Weize,Wu Jiayuan,Li Daheng,Zhang Liangqing,Huang Bing,Tang Jing
Abstract
AbstractRadiofrequency ablation (RFA) comparative efficacy of treatments using video-assisted thoracoscopic sympathectomy (VATS) in the long term remains uncertain in patients with palmar hyperhidrosis (PHH). This study aimed to compare the efficacy and safety of RFA and VATS in patients with PHH. We recruited patients aged ≥ 14 years with diagnosed PHH from 14 centres in China. The treatment options of RFA or VATS were assigned to two cohort in patients with PHH. The primary outcome was the efficacy at 1-year. A total of 807 patients were enrolled. After propensity score matching, the rate of complete remission was lower in RFA group than VATS group (95% CI 0.21–0.57; p < 0.001). However, the rates of palmar dryness (95% CI 0.38–0.92; p = 0.020), postoperative pain (95% CI 0.13–0.33; p < 0.001), and surgery-related complications (95% CI 0.19–0.85; p = 0.020) were lower in RFA group than in VATS group, but skin temperature rise was more common in RFA group (95% CI 1.84–3.58; p < 0.001). RFA had a lower success rate than VATS for the complete remission of PHH. However, the symptom burden and cost are lower in patients undergoing RFA compared to those undergoing VATS.Trial Registration: ChiCTR2000039576, URL: http://www.chictr.org.cn/index.aspx.
Funder
Science and Technology Plan Project of Zhanjiang
Science and Technology Plan Project of Jiaxing
National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
Key Projects of Guangdong Natural Science Foundation
Publisher
Springer Science and Business Media LLC